Combined analysis of r-1,t-2,3,c-4-tetrahydroxy-1,2,3,4- tetrahydrophenanthrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in smokers' plasma

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 8, 2006, Pages 1490-1494

  Carmella, Steven G ^a   Yoder, Andrea ^a   Hecht, Stephen S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; BETA GLUCURONIDASE; BIOLOGICAL MARKER; CARCINOGEN; NITROSAMINE; PHENANTHRENE DERIVATIVE; POLYCYCLIC AROMATIC HYDROCARBON; TETRAHYDROXY 1,2,3,4 TETRAHYDROPHENANTHRENE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; PRIORITY JOURNAL; SMOKING; SMOKING HABIT; SOLID PHASE EXTRACTION;

BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GLUCURONIDASE; HUMANS; NITROSAMINES; PHENANTHRENES; PYRIDINES; SMOKING;

EID: 33748041085     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-0199     Document Type: Article

References (18)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. International Agency for Research on Cancer. Tobacco smoke and involuntary smoking. IARC Monographs on the evaluation of carcinogenic risks to humans. Vol. 83. Lyon (France): IARC; 2004. p. 53-119.
3. Hecht SS. Tobacco carcinogens, their biomarkers, and tobacco-induced cancer. Nat Rev Cancer 2003;3:733-44.
4. Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999;91:1194-210.
5. Joseph AM, Hecht SS, Murphy SE, et al. Relationships between cigarette consumption and biomarkers of tobacco toxin exposure. Cancer Epidemiol Biomarkers Prev 2005;14:2963-8.
6. Cooper CS, Grover PL, Sims P. The metabolism and activation of benzo[a]pyrene. Prog Drug Metab 1983;7:295-396.
7. Conney AH. Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G.H.A. Clowes Memorial Lecture. Cancer Res 1982;42:4875-917.
8. Szeliga J, Dipple A. DNA adduct formation by polycyclic aromatic hydrocarbon dihydrodiol epoxides. Chem Res Toxicol 1998;11:1-11.
9. Pfeifer GP, Denissenko MF, Olivier M, et al. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 2002;21:7435-51.
10. Hecht SS, Chen M, Yagi H, et al. r-1,t-2,3,c-4-Tetrahydroxy-1,2,3,4- tetrahydrophenanthrene in human urine: a potential biomarker for assessing polycyclic aromatic hydrocarbon metabolic activation. Cancer Epidemiol Biomarkers Prev 2003;12:1501-8.
11. Hecht SS, Chen M, Yoder A, et al. Longitudinal study of urinary phenanthrene metabolite ratios: effect of smoking on the diol epoxide pathway. Cancer Epidemiol Biomarkers Prev 2005;14:2969-74.
12. Hecht SS. Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis 2002;23:907-22.
13. Carmella SG, Han S, Villalta PW, et al. Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in smokers' blood. Cancer Epidemiol Biomarkers Prev 2005;14:2669-72.
14. Carmella SG, Akerkar S, Richie JP, Jr., et al. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine. Cancer Epidemiol Biomarkers Prev 1995;4:635-42.
15. Barr DB, Wilder LC, Caudill SP, et al. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect 2005;113:192-200.
16. Kim JY, Hecht SS, Mukherjee S, et al. A urinary metabolite of phenanthrene as a biomarker of polycyclic aromatic hydrocarbon metabolic activation in workers exposed to residual oil fly ash. Cancer Epidemiol Biomarkers Prev 2005;14:687-92.
17. Hecht SS. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol 1998;11:559-603.
18. Hecht SS, Hatsukami DK, Bonilla LE, et al. Quantitation of 4-oxo-4-(3-pyridyl)butanoic acid and enantiomers of 4-hydroxy-4-(3-pyridyl) butanoic acid in human urine: a substantial pathway of nicotine metabolism. Chem Res Toxicol 1999;12:172-9.